Company Overview
Cell Therapy Catapult Limited is listed at the official companies registry as Active Private Limited By Guarantee Without Share Capital. The company was incorporated on Friday 24 February 2012, so this is a well established company. Cell Therapy Catapult Limited has been in business for 14 years and 1 month. The accounts status is group and the accounts are next due on Wednesday 31 December 2025.
Registered Address

12Th Floor Tower Wing B, Guys Hospital, London, SE1 9RT
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameCELL THERAPY CATAPULT LIMITED
Company Number07964711
Registered Office Address12th Floor Tower Wing B
 Guys Hospital
 SE1 9RT
Company CategoryPrivate Limited By Guarantee Without Share Capital
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date24/02/2012
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryGROUP
Returns Next Due Date28/04/2017
Returns Last Made Up Date31/03/2016
Directors & Members
Show Resigned
Jacqueline Barry - Director
(British, 61 years old, born June 1965)
Appointed 04 February 2017
 Active
Steven Chatfield - Director
(British, 69 years old, born January 1957)
Appointed 01 January 2016
 Active
Matthew Durdy - Director
(British, 60 years old, born June 1966)
Appointed 01 January 2016
 Active
Jim Faulkner - Director
(British, 61 years old, born May 1965)
Appointed 25 April 2024
 Active
Uta Griesenbach - Director
(German, 62 years old, born January 1964)
Appointed 01 September 2018
 Active
Bruce Keogh - Director
(British, 72 years old, born November 1954)
Appointed 01 September 2018
 Active
Hsin Loke - Director
(Malaysian, 54 years old, born September 1972)
Appointed 01 September 2024
 Active
Nicole Mather - Director
(British, 52 years old, born August 1974)
Appointed 25 April 2024
 Active
Hilary Newiss - Director
(British, 70 years old, born April 1956)
Appointed 01 September 2018
 Active
Carolyn Porter - Director
(British, 56 years old, born July 1970)
Appointed 25 April 2024
 Active
Angela Thomas - Director
(British, 69 years old, born June 1957)
Appointed 13 October 2020
 Active
Stephen Ward - Director
(British, 56 years old, born June 1970)
Appointed 01 January 2016
 Active
Secretaries
Show Resigned
Other Company Directorships
Jacqueline Barry
CELL THERAPY CATAPULT SERVICES LIMITED
CGTC MANUFACTURING INNOVATION CENTRE LIMITED
GLOBAL ALLIANCE FOR IPSC THERAPIES LIMITED
Steven Chatfield
BARINTHUS BIOTHERAPEUTICS (UK) LIMITED
BIORESOLVE LIMITED
EMERGENT PRODUCT DEVELOPMENT UK LIMITED
IMOPHORON LIMITED
OXFORD-EMERGENT TUBERCULOSIS CONSORTIUM LIMITED
PHTA LTD
PROKARIUM HOLDINGS LTD
PROKARIUM LIMITED
STABLEPHARMA LIMITED
VACCINE MANUFACTURING AND INNOVATION CENTRE UK LIMITED
Matthew Durdy
AQIX LTD
AUGHT LIMITED
BIOTEC LABORATORIES LIMITED
CELL AND GENE THERAPY CATAPULT
CELL MEDICA TCR LIMITED
CELL THERAPY CATAPULT SERVICES LIMITED
CGTC MANUFACTURING INNOVATION CENTRE LIMITED
CHIMERIC THERAPEUTICS LIMITED
GLOBAL ALLIANCE FOR IPSC THERAPIES LIMITED
PARKINSON'S DISEASE SOCIETY OF THE UNITED KINGDOM
PARKINSON'S RESEARCH VENTURES LIMITED
THE TERENCE BEER CHILDREN`S TRUST
Jim Faulkner
No companies found
Uta Griesenbach
ALVEOGENE LIMITED
BRITISH SOCIETY FOR GENE AND CELL THERAPY
Bruce Keogh
ARCTURIS DATA LIMITED
BIRMINGHAM WOMEN'S AND CHILDREN'S HOSPITAL CHARITY
EACTS TRADING COMPANY LIMITED
EUROPEAN ACADEMY FOR THORACIC AND CARDIAC SURGERY LIMITED
PICKER INSTITUTE EUROPE
THE SOCIETY FOR CARDIOTHORACIC SURGERY IN GREAT BRITAIN AND IRELAND
Hsin Loke
BOOKTRUST
Nicole Mather
GENOME RESEARCH LIMITED
Hilary Newiss
ENGLISH NATIONAL OPERA
FUTURE CARE CAPITAL
THE ROSALIND FRANKLIN INSTITUTE
Carolyn Porter
HONE BIO LIMITED
OUTRUN THERAPEUTICS LIMITED
Angela Thomas
EDINBURGH CHILDREN'S HOSPITAL CHARITY
FETTES COLLEGE
IPHOUM (MANAGEMENT) LTD
KISSING IT BETTER
THE BRITISH SOCIETY FOR HAEMATOLOGY
THE FACULTY OF PHARMACEUTICAL MEDICINE OF THE ROYAL COLLEGES OF PHYSICIANS OF THE UNITED KINGDOM
TRANSFUSION MEDICINE EDUCATION & RESEARCH FOUNDATION
UKHCDO LIMITED
Stephen Ward
CELL THERAPY CATAPULT SERVICES LIMITED
CGTC MANUFACTURING INNOVATION CENTRE LIMITED
IOSBIO LTD
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2015 31-Mar-2014
Balance Sheet
Fixed Assets 9,592,000 9,592,000 8,924,000
Current Assets 11,210,000 11,210,000 12,083,000
Creditors Due Within One Year 4,568,000 4,568,000 12,078,000
Working Cap 6,642,000 6,642,000 5,000
Total Assets Less Current Liabilities 16,234,000 16,234,000 8,929,000
Long-term Liabilities 8,541,000 8,541,000 1,772,000
Net Assets 7,693,000 7,693,000 7,157,000
Share Capital & Reserves
Share Cap 0 0 0
Profit & Loss Reserves 7,693,000 7,693,000 7,157,000
Other Reserves 0 0 0
Shareholders Funds 7,693,000 7,693,000 7,157,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2015 31-Mar-2014
Tangible Fixed Assets - - -
Fixed Assets 46.1% 46.1% 42.5%
Stocks Inventory 0.0% 0.0% 0.0%
Debtors 1.2% 1.2% 0.3%
Cash Bank In Hand 17.5% 17.5% 22.7%
Current Assets 53.9% 53.9% 57.5%
Creditors Due Within One Year 22.0% 22.0% 57.5%
Net Current Assets Liabilities 31.9% 31.9% 0.0%
Creditors Due After One Year 41.1% 41.1% 8.4%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 37.0% 37.0% 34.1%
Called Up Share Capital 0.0% 0.0% 0.0%
Share Capital Allotted Called Up Paid 0.0% 0.0% 0.0%
Profit Loss Account Reserve 37.0% 37.0% 34.1%
Shareholder Funds 37.0% 37.0% 34.1%
Capital Employed - - -
Total Assets Less Current Liabilities 78.0% 78.0% 42.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2015 31-Mar-2014
Liquidity Ratio 2.5 2.5 1.0
Solvency Ratio 1.6 1.6 1.5
Reserves to Assets 0.4 0.4 0.3
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 2
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2015 31-Mar-2014
Assets 20,802,000 20,802,000 21,007,000
Debt 13,109,000 13,109,000 13,850,000
Net Assets/Debt 7,693,000 7,693,000 7,157,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around SE1 9RT
CELL THERAPY CATAPULT SERVICES LIMITED
12TH FLOOR TOWER WING B, GUYS HOSPITAL, LONDON, SE1 9RT
GLOBAL ALLIANCE FOR IPSC THERAPIES LIMITED
12th Floor Tower Wing Guy's Hospital, Great Maze Pond, London, SE1 9RT
BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY
Bsbmtct Data Registry C/O Guy's Hospital, Great Maze Pond, London, SE1 9RT
SHOPITAL LIMITED
Jade House,, 67 Park Royal Road, London, SE1 9RT
KING'S HEALTH PARTNERS LIMITED
Ground Floor Counting House, Guy's Hospital, Great Maze Road, London, SE1 9RT
CHIMERIC THERAPEUTICS LIMITED
12th Floor Tower Wing Guys Hospital, Great Maze Pond, London, SE1 9RT
SPOTON CLINICAL DIAGNOSTICS LIMITED
SPOTON CLINICAL DIAGNOSTICS SUITE 10, FIRST FLOOR, QMB INNOVATION CENTRE, 42 NEW ROAD, LONDON, SE1 9RT
GUY'S AND ST THOMAS' HOSPITAL KIDNEY PATIENTS' ASSOCIATION
RENAL OFFICES 6TH FLOOR BOROUGH WING GUY'S HOSPITAL, GREAT MAZE POND, LONDON, SE1 9RT
CELL AND GENE THERAPY CATAPULT
12th Floor Tower Wing Guy's Hospital, Great Maze Pond, London, SE1 9RT
PRECISION DIAGNOSTIC ANALYTICS LIMITED
1st Floor Counting House, Guys Hospital, Great Maze Pond, London, SE1 9RT
Document Filings
Register inspection address has been changed from Law Deb, 2 New Bailey 6 Stanley Street Manchester M3 5GS United Kingdom to 12th Floor Tower Wing B Guy's Hospital London SE1 9RT
Termination of appointment of Ian Mccubbin as a director on 31 July 2025
Confirmation statement made on 31 March 2025 with no updates
Director's details changed for Mr Ian Mccubbin on 6 March 2025
Resolutions
Appointment of Dr Hsin Loke as a director on 1 September 2024
Termination of appointment of Christine Helen Soden as a director on 31 July 2024
Resolutions
Resolutions
Second filing for the appointment of Dr Carolyn Porter as a director
Appointment of Dr Nicole Mather as a director on 25 April 2024
Appointment of Dr Carolyn Porter as a director on 24 April 2024
Appointment of Mr Jim Faulkner as a director on 25 April 2024
Termination of appointment of Ian William Campbell as a director on 31 March 2024
Confirmation statement made on 31 March 2024 with no updates
Confirmation statement made on 31 March 2023 with no updates
Termination of appointment of Stuart Jonathon Brodie Henderson as a director on 1 August 2022
Termination of appointment of Simon Crossley as a secretary on 19 August 2022
Secretary's details changed for Simon Crossley on 2 July 2021
Confirmation statement made on 31 March 2022 with no updates
Director's details changed for Dr Ian William Campbell on 1 January 2022
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free